Physicians cover the options for a patient with hormone receptor–positive, HER2-negative, early-stage breast cancer, which course of action they would take, and the data supporting that choice.
Maisey Ratcliffe, MPH
Maisey Ratcliffe, MPH, is a clinical research coordinator III at Emory University.
Articles by Maisey Ratcliffe, MPH
Latest Updated Articles
Management of HR+, HER2- Early-Stage Breast Cancer After DiagnosisPublished: June 1st 2022 | Updated: